Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
Holding BNTC?
Track your performance easily
BNTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.69 - $10.88
Previous Close$8.36
Volume5.00K
Average Volume (3M)28.21K
Market Cap
$87.47M
Enterprise Value$84.67M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$354.00K
Price to Earnings (P/E)―
Beta1.17
Next Earnings
Nov 11, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jun 01, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-9.87
Shares Outstanding10,090,000
10 Day Avg. Volume17,226
30 Day Avg. Volume28,213
Standard Deviation0.26
R-Squared0.03
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)7.33
Price to Sales (P/S)17969.63
Price to Cash Flow (P/CF)-5.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.57K
Enterprise Value/Gross Profit1.13K
Enterprise Value/Ebitda-5.05
Forecast
1Y Price Target
$19.00Price Target Upside119.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Benitec Biopharma News
PremiumCompany Announcements
Benitec Biopharma Shareholders Approve Key Proposals
PremiumCompany Announcements
Benitec Biopharma Reports Promising Interim Study ResultsOwnership Overview
10.69%
Insiders
5.94% Mutual Funds
29.00% Other Institutional Investors
54.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
BNTC FAQ
What was Benitec Biopharma Ltd’s price range in the past 12 months?
Benitec Biopharma Ltd lowest stock price was $2.69 and its highest was $10.88 in the past 12 months.
What is Benitec Biopharma Ltd’s market cap?
Currently, no data Available
When is Benitec Biopharma Ltd’s upcoming earnings report date?
Benitec Biopharma Ltd’s upcoming earnings report date is Nov 11, 2024 which is in 52 days.
How were Benitec Biopharma Ltd’s earnings last quarter?
Currently, no data Available
Is Benitec Biopharma Ltd overvalued?
According to Wall Street analysts Benitec Biopharma Ltd’s price is currently Undervalued.
Does Benitec Biopharma Ltd pay dividends?
Benitec Biopharma Ltd pays a Notavailable dividend of $0.51 which represents an annual dividend yield of N/A. See more information on Benitec Biopharma Ltd dividends here
What is Benitec Biopharma Ltd’s EPS estimate?
Benitec Biopharma Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Benitec Biopharma Ltd have?
Benitec Biopharma Ltd has 10,086,119 shares outstanding.
What happened to Benitec Biopharma Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Benitec Biopharma Ltd?
Currently, no hedge funds are holding shares in BNTC
---
Benitec Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.00 (119.08% Upside)
$19.00 (119.08% Upside)
Blogger Sentiment
Bullish
BNTC Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
187.28%
12-Months-Change
Fundamentals
Return on Equity
-267.59%
Trailing 12-Months
Asset Growth
82.47%
Trailing 12-Months
Company Description
Benitec Biopharma Ltd
Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in North Sydney, Australia.
---
BNTC Stock 12 Month Forecast
Average Price Target
$19.00
▲(119.08% Upside)
Technical Analysis
Adaptimmune Therapeutics
―
Crispr Therapeutics AG
―
Editas Medicine
―
Intellia Therapeutics
―
Best Analysts Covering BNTC
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+62.91%
reiterated a buy rating 2 months ago
Copying Silvan Tuerkcan's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +62.91% per trade.
---